SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950133-08-002566
Filing Date
2008-07-30
Accepted
2008-07-30 17:31:40
Documents
7
Period of Report
2008-07-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K w64199e8vk.htm 8-K 15678
2 EX-4.1 w64199exv4w1.htm EX-4.1 64564
3 EX-5.1 w64199exv5w1.htm EX-5.1 7962
4 EX-10.1 w64199exv10w1.htm EX-10.1 166700
5 EX-10.2 w64199exv10w2.htm EX-10.2 37642
6 EX-99.1 w64199exv99w1.htm EX-99.1 8039
7 GRAPHIC w64199w6419901.gif GRAPHIC 9806
  Complete submission text file 0000950133-08-002566.txt   315764
Mailing Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850
Business Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 08979876
SIC: 2836 Biological Products, (No Diagnostic Substances)